Christina Jenkins

Fund(s): Active Aging & Longevity, FemTech Fund I & II
Location: New York

Dr. Christina Jenkins, MD (“CJ”) is a venture investor and adviser who uses technology and trusted relationships to improve health, at scale.

Dr. Jenkins is a Venture Partner at Phoenix Venture Partners, leading investments in seed and early-stage digital health and hardware-enabled platform companies used for diagnostics or monitoring. She is also a Lead Investor (Venture Partner) for Portfolia’s Femtech and Active Aging and Longevity funds.

Separately, Dr. Jenkins is a National Advisor to Manatt Health, a division of Manatt Phelps and Phillips. There, she supports leaders in health system redesign and growth strategies, integrated care strategies, and clinical value improvement.

Previously, she was the founding CEO of OneCity Health, a population-health focused subsidiary of NYC Health and Hospitals, the nation’s largest public hospital system. There, she led a $1.2B effort to accelerate value-based payment readiness for 1M low-income New Yorkers through effecting novel tech platforms and integrated care models across the care continnuum.

She is a Board Director or Observer of venture-backed companies Xandar Kardian, Madorra, and FIGUR8. She is also a Board Director of Predictive Oncology (NASDAQ: POAI), and a Board Advisor to Independence Health Group (parent of Independence Blue Cross and AmeriHealth Caritas). She was previously a Bloomberg appointee to the board of NYC Health and Hospitals, serving as Board Chair of its Quality and Performance Committee, and a member of the Quality Committee of Healthfirst, a 1.2M member health plan.

Dr. Jenkins is a former practicing internist trained at Mount Sinai in New York, where she served as a Clinical Instructor in Medicine and helped to build a housecall practice. She is a Kauffman Fellow (New Enterprise Associates) and earned her M.D from Northwestern University and her B.S. in Industrial Management at Purdue University.